Conferences  >  Medicine & Healthcare  >  Oncology  >  United States

IDEOlogy Health

IDEOlogy Health has developed this educational meeting that will engage physicians and allied health professionals on the latest advances for the treatment of lung cancer. The goal of this activity is to provide a comprehensive update to medical oncologists and healthcare providers (academic and community) on the evolving treatments in thoracic oncology.

oncology, thoracic oncology, lung cancer, cancer, surgical oncology, immunotherapy, cme

Binaytara Foundation

The “BTF Multidisciplinary Breast Cancer Conference” is a CME-accredited activity featuring experts in breast cancer. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with breast cancer. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in field. Expert faculty will aim to place the role of different therapeutic agents in clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Phone: [4255575953];     Email: meggan.m@binayfoundation.org

breast cancer, cancer, oncology, cme, medical, healthcare, conference,

Baptist Health South Florida, CME

The Miami Cancer Institute Women’s Cancer Symposium brings together a distinguished faculty for a one-day live symposium that will focus on the medical management of common and important challenges facing healthcare professionals who care for women with cancer. The multispecialty approach allows participants to explore new diagnoses and cutting-edge treatment options for various areas of breast and ovarian cancer patient care in a concise symposium format.

Email: kamilap@baptisthealth.net

Continuing Medical Education (CME),    Obstetrics/Gynecology

Binaytara Foundation

This annual oncology conference, 2023 Summit on Cancer Health Disparities: Reframing and addressing barriers to adoption of precision oncology, will feature lectures, panel discussions and debates among leaders across the spectrum of cancer care delivery. This conference will bring together oncology professionals, cancer disparity researchers, and other stakeholders to discuss the factors leading to cancer health disparities and ways to overcome the impact of these factors to optimize outcomes of cancer patients.

Phone: [4255575953];     Email: meggan.m@binayfoundation.org

Oncologist and Hematologists, Oncology and Hematology Nurse Practitioners, Oncology and Hematology Physician Assistants, Oncology and Hematology Nurses, Oncology and Hematology Pharmacists, Oncology and Hematology Fellows/Residents, Oncology and Hematology Researchers, Others interested in cancer disparities

Binaytara Foundation

The Alaska Multidisciplinary Oncology Conference is a 1-day educational and scientific meeting that will focus on key clinical topics in the management of common malignancies. This conference will feature leading experts discussing the latest diagnostic, therapeutic, and supportive care strategies in cancer management. The field of oncology is continually evolving with the introduction of new targeted therapies, cellular therapies, and immunotherapy. These advances present new opportunities to tailor treatment approaches for cancer patients based on disease-related and patient-related factors. Significant disparities exist in access to continuing education for physicians practicing in rural settings. Engaging, easily accessible continuing education activities focusing on content that has practical applications for the provider may significantly impact patient outcomes. There is a need for these educational activities in rural settings to update practicing healthcare providers about recent advances in the field. This highly practical and interactive symposium will provide a unique opportunity for healthcare professionals to learn from and interact with well-known experts in the field.

Phone: [4255575953];     Email: meggan.m@binayfoundation.org

Oncology, Medical, Cancer, Conference

Binaytara Foundation

This CME-accredited activity “Multiple Myeloma & Lymphoma Summit” features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for management of multiple myeloma, lymphoma, and Waldenström Macroglobulinemia. The goal of this activity is to improve the knowledge and competence of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in newly diagnosed and relapsed multiple myeloma and lymphomas with a focus on emerging immunotherapies, including but not limited to, CAR-T therapy and T-cell redirecting bispecific antibodies. Expert faculty will aim to place the role of different therapeutic agents in clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Event and Communication Assistant;     Phone: [4255575953];     Email: tiani.g@binayfoundation.org

conference, CME, continuing education, oncology, utah, cancer research, healthcare equity

Hematology,    Continuing Medical Education (CME)

Binaytara Foundation

This CME-accredited oncology conference, Best of ASCO 2023, Portland, is designed to improve the care of cancer patients by educating clinicians involved in cancer care.

This oncology conference features some of the most well-known experts in the field of hematology and oncology who will provide a comprehensive overview of noteworthy data presented at the 2023 ASCO® Annual Meeting (ASCO2023) in June of 2023. The program includes in-depth discussion and analysis of the latest scientific findings and practice-changing advances in the field and a scientific abstract session. Expert faculty will place abstract findings from ASCO2023 into clinical context and discuss how the results may change the current standard of care.

Event Planner;     Phone: [4255575953];     Email: shahtara@binayfoundation.org

ASCO, BTF

Binaytara Foundation

CME-accredited oncology conference being held in person in Seattle, WA. This conference features lectures and discussions with leading experts in cellular therapies. The goal of this oncology conference is to improve the knowledge, competence, and performance of learners to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients receiving cellular therapies for hematologic and non-hematologic disorders. The conference agenda includes an in-depth discussion and analysis of the latest scientific findings and practice-changing advances in chimeric antigen receptor (CAR) based therapies. Expert faculty will aim to place the role of different therapeutic agents in a clinical context and discuss how to utilize these therapeutic options to effectively contribute to patient care.

Event Planner;     Phone: [4255575953];     Email: support@binayfoundation.org

CLL/NHL, ALL, MULTIPLE MYELOMA, SOLID TUMORS, SUPPORTIVE CARE

Continuing Medical Education (CME),    Hematology

Binaytara Foundation

This CME-accredited activity 2023 Annual Summit on Hematologic Cancers features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, myeloproliferative neoplasms, multiple myeloma, and lymphoma.

Event Planner;     Phone: [4255575953];     Email: support@binayfoundation.org

Oncology, cancer, CME, hematology malengenices, acute myeloid leukemia, acute lymphoblastic leukemia, chronic lymphocytic leukemia, chronic myeloid leukemia, myeloproliferative neoplasms, multiple myeloma, lymphoma, btf

Bio Ascend LLC

The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) is a biennial meeting focused solely on advancing the understanding and treatment of chronic lymphocytic leukemia (CLL) and related lymphoproliferative disorders. Founded in 1979, iwCLL is now the largest international meeting dedicated to advancing state-of-the-art and emerging concepts—from laboratory-based research to the clinic—in the pathobiology and treatment of these blood cancers. The biennial meeting is intended to provide a forum that promotes the exchange of information and encourages collaboration among international leaders and scientists interested in CLL and lymphoproliferative disorders in one location for 4 days every other year.

Chronic lymphocytic Leukemia, ( CLL)

Continuing Medical Education (CME),    Hematology

Binaytara Foundation

The 2023 Precision Oncology Summit: Personalizing Treatment to Improve Patient Outcomes is an oncology conference featuring leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies.

Expert faculty will discuss and analyze the latest scientific findings and practice-changing advances in precision oncology, including the key abstracts relevant to precision oncology presented at the 2023 ASCO Annual Meeting in June 2023.

Event Planner;     Phone: [4255575953];     Email: support@binayfoundation.org

oncology, CME-credits